8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      T cells with dysfunctional mitochondria induce multimorbidity and premature senescence

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The impact of immunometabolism on age-associated diseases remains uncertain. Here, we show that T cells with dysfunctional mitochondria due to mitochondrial transcription factor A (TFAM) deficiency act as accelerators of senescence. In mice, these cells instigate multiple aging-related features, including metabolic, cognitive, physical, and cardiovascular alterations, which together result in premature death. T cell metabolic failure induces the accumulation of circulating cytokines, which resembles chronic inflammation characteristic of aging ("inflammaging"). This cytokine storm itself acts as a systemic inducer of senescence. Blocking TNF-α signaling or preventing senescence with NAD+ precursors partially rescues premature aging in mice with Tfam-deficient T cells. Thus, T cells can regulate organismal fitness and lifespan, highlighting the importance of tight immunometabolic control in both aging and the onset of age-associated diseases.

          Related collections

          Author and article information

          Journal
          Science
          Science
          American Association for the Advancement of Science (AAAS)
          0036-8075
          1095-9203
          May 21 2020
          : eaax0860
          Affiliations
          [1 ]Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
          [2 ]Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid (UAM), Madrid, Spain.
          [3 ]Hospital Universitario de la Princesa, Madrid, Spain.
          [4 ]Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.
          [5 ]Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
          [6 ]Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
          [7 ]Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
          [8 ]IIS-Fundación Jiménez Díaz, Madrid, Spain.
          [9 ]Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
          [10 ]Bone Physiopathology Laboratory, Applied Molecular Medicine Institute (IMMA), Universidad San Pablo-CEU, Madrid, Spain.
          [11 ]Metabolic Syndrome Group - BIOPROMET, Madrid Institute for Advanced Studies - IMDEA Food, CEI UAM+CSIC, Madrid, Spain.
          [12 ]Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
          Article
          10.1126/science.aax0860
          32439659
          8ff3de47-d792-48b2-ab5a-313fa6054764
          © 2020
          History

          Comments

          Comment on this article